Tsvetelina Lazarova
About Tsvetelina Lazarova
Tsvetelina Lazarova Education
Tsvetelina Lazarova received a B.A. degree in chemistry from Harvard University. She furthered her education by earning an M.A. in organic chemistry from MIT. She completed her academic journey with a PhD in organic chemistry from the University of California, Los Angeles. Her studies were conducted under the mentorship of renowned professors such as Stuart Schreiber, Stephen Buchwald, and Michael E. Jung.
Tsvetelina Lazarova Professional Background
Tsvetelina Lazarova initiated her professional career at Enanta Pharmaceuticals, where she spearheaded the chemistry portion of the immunology program. At Daiichi Asubio Research Laboratories, she led the nuclear hormone receptor project. Her work at ARIAD Pharmaceuticals focused on peptide mimetics involved in signal transduction pathways. During her tenure at Cubist Pharmaceuticals, she designed and synthesized second-generation analogs of Daptomycin.
Tsvetelina Lazarova Co-Founder Role
Tsvetelina Lazarova holds the title of Co-Founder. Her experience and expertise in organic chemistry have significantly contributed to her leadership role. Details on the specific company or initiative she co-founded were not provided, but her extensive background in pharmaceuticals and organic chemistry highlights her capabilities in this position.
Tsvetelina Lazarova Achievements in Pharmacology
Tsvetelina Lazarova has achieved notable success in the field of pharmacology. At Enanta Pharmaceuticals, she advanced two lead series to pre-clinical status as potential therapies for asthma and psoriasis. These achievements underscore her contributions to the development of novel therapeutic strategies and her role in advancing drug development processes.